Acorda Therapeutics Stock (NASDAQ: ACOR) stock price, news, charts, stock research, profile.
Open | $12.390 |
Close | $13.211 |
Volume / Avg. | 4.617K / 3.823K |
Day Range | 11.820 - 13.315 |
52 Wk Range | 8.978 - 24.196 |
Market Cap | $15.402M |
P/E Ratio | 4.563 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 0.83% |
Days to Cover | 6.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acorda Therapeutics (NASDAQ: ACOR) through any online brokerage.
Other companies in Acorda Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Acorda Therapeutics (NASDAQ: ACOR) was reported by HC Wainwright & Co. on Thursday, June 17, 2021. The analyst firm set a price target for 10.00 expecting ACOR to fall to within 12 months (a possible -19.35% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Acorda Therapeutics (NASDAQ: ACOR) is $12.4 last updated March 27, 2024 at 9:24 AM EDT.
There are no upcoming dividends for Acorda Therapeutics.
Acorda Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Acorda Therapeutics.
Acorda Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.